Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrotron vs Ferrous Fumarate in Pregnancy-Related Iron Deficiency Anemia
NCT03830034Phase 4Unknown
- Sponsor
- Ain Shams University
- Start
- Feb 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of Ferrotron in iron deficiency anemia (IDA) (2 arms), sponsored by Ain Shams University. Primary endpoint: Hemoglobin Rise at 12 weeks. Status: unknown.
02
Drugs
Ferrotron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT03830034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03830034.